Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$271 Million13.79% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$142 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$133 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$127 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.5MShares$103 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.51B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...